Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

[Molecular targeted drugs against ALK fusions].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica - 1 Jul 2011

Mano Hiroyuki

Abstract excerpt

No abstract is available from the source.

Topics

Animals
Antineoplastic Agents
Clinical Trials as Topic
Crizotinib
Drug Resistance, Neoplasm
Humans
Lung Neoplasms
Mice
Molecular Targeted Therapy
Mutation
Oncogene Proteins, Fusion
Pathology, Molecular
Pyrazoles
Pyridines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21747201
DOI: 10.1254/fpj.138.3

Genes

ALK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular targeted drugs against ALK fusions].PMID 21747201Read ↗

Targeting drug-resistant mutations in ALK.Semantic proximity Read ↗

EML4-ALK: Update on ALK InhibitorsSemantic proximity Read ↗

New perspectives for targeting therapy in ALK-positive human cancersSemantic proximity Read ↗

ALK gene alterations in cancer: biological aspects and therapeutic implications.Semantic proximity Read ↗

RET-oncogene-targeting drugs draw notice.Semantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenarioSemantic proximity Read ↗

[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].Semantic proximity Read ↗

A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.Semantic proximity Read ↗

Targeting oncogenic ALK: a promising strategy for cancer treatment.Semantic proximity Read ↗

ALK and ROS1 non-small-cell lung cancer: two molecular subgroups sensitive to targeted therapy.Semantic proximity Read ↗

EGFR antagonists in cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.